Suscripción a Biblioteca: Guest
Portal Digitalde Biblioteca Digital eLibros Revistas Referencias y Libros de Ponencias Colecciones
International Journal of Medicinal Mushrooms
Factor de Impacto: 1.423 Factor de Impacto de 5 años: 1.525 SJR: 0.431 SNIP: 0.661 CiteScore™: 1.38

ISSN Imprimir: 1521-9437
ISSN En Línea: 1940-4344

Volumen 21, 2019 Volumen 20, 2018 Volumen 19, 2017 Volumen 18, 2016 Volumen 17, 2015 Volumen 16, 2014 Volumen 15, 2013 Volumen 14, 2012 Volumen 13, 2011 Volumen 12, 2010 Volumen 11, 2009 Volumen 10, 2008 Volumen 9, 2007 Volumen 8, 2006 Volumen 7, 2005 Volumen 6, 2004 Volumen 5, 2003 Volumen 4, 2002 Volumen 3, 2001 Volumen 2, 2000 Volumen 1, 1999

International Journal of Medicinal Mushrooms

DOI: 10.1615/IntJMedMushrooms.2018028771
pages 1065-1074

Studies of the Antimicrobial Activity of Mushrooms (Agaricales) from South America (Review)

Marina Giombelli Rosenberger
Graduate Program in Botany, Federal University of Parana, Curitiba, PR, Brazil
Roberta Paulert
Department of Agronomic Sciences, Federal University of Parana, Palotina, PR, Brazil
Vagner G. Cortez
Graduate Program in Botany, Federal University of Parana, Curitiba, PR, Brazil


South America harbors much of the world's biodiversity, representing a potential reservoir of species with diverse possibilities for use. From this perspective, mushroom species are included because they naturally produce a wide variety of substances, especially ones with antimicrobial activity. In this article we present a review of the literature on the antimicrobial activity of mushrooms collected in South America, emphasizing the bacteria and fungi these mushrooms inhibit, the main methodologies researchers use for antimicrobial tests, and some directions for future research. This review demonstrates that the agar diffusion test was the most prevalent method in studies of South American mushrooms. Most studies dealt with specimens collected in Chile (16 species), Brazil (10 species), and Uruguay (2 species), and 27 of those species presented antimicrobial activity. Furthermore, most research developed with Basidiomycetes in South America aimed only to screen antimicrobial agents, whereas few studies explored the antimicrobial potential of purified secondary metabolites. Thus it is very important to conduct research in order to screen for and isolate antimicrobial substances, which researchers can then use to develop new antimicrobial drugs.

Articles with similar content:

Evaluation of Therapeutic Activity of Hypogeous Ascomycetes and Basidiomycetes from North America
International Journal of Medicinal Mushrooms, Vol.9, 2007, issue 1
Rita Stanikunaite, Samir A. Ross, Shabana I. Khan, James M. Trappe
Comparison of Antioxidant and Antiproliferation Activities of Polysaccharides from Eight Species of Medicinal Mushrooms
International Journal of Medicinal Mushrooms, Vol.17, 2015, issue 3
Yangyang Yong, Yifan Gu, Zeliang Wang, Shizhu Zhang, Peiying Chen, Ling Lu
Higher Basidiomycota as a Source of Antitumor and Immunostimulating Polysaccharides (Review)
International Journal of Medicinal Mushrooms, Vol.3, 2001, issue 4
Sergey V. Reshetnikov, Kok- Kheng Tan
Biotechnological Potential of Mushrooms: Drugs and Dye Production
International Journal of Medicinal Mushrooms, Vol.7, 2005, issue 3
Girish Tidke, Mahendra K. Rai
Current Advances in the Antimicrobial Potential of Species of Genus Ganoderma (Higher Basidiomycetes) against Human Pathogenic Microorganisms (Review)
International Journal of Medicinal Mushrooms, Vol.17, 2015, issue 10
Mahendra K. Rai, Carolina Alves dos Santos, Dipali Nagaonkar, Swapnil Gaikwad